FDA delays cost Americans trillions and slow lifesaving drugs, new report says
A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from faster medical innovation.
Related News
Fourth US drug boat strike in a week kills more 'narco-terrorists'
After three other vessel strikes last week, U.S. Southern Command reported that another strike that left three "narco-t…
Congress returns with GOP agenda stalled over DOJ's "anti-weaponization" fund
Congress is returning from recess to resume work on funding immigration agencies, following a GOP revolt over the Trump…
Senate Democrats launch campaign to kill DOJ's "anti-weaponization" fund
Senate Democrats are launching a coordinated effort to kill the Trump administration's $1.7+ billion "anti-weaponizatio…
Trump flips script on left, maneuvers to use foreign influence law against the them
Trump aims to use FARA and other legal tools against alleged foreign influence on the left after years of probes target…
James Comey '86 47' seashell case prosecutor suddenly steps down, assistant US attorney steps in
A new court filing reveals the lead prosecutor in the James Comey "86 47" seashell case has been replaced ahead of the …
Congress barrels toward deadline pile-up as GOP divisions threaten Trump agenda
Congress returns to unfinished business as Republican divisions over budget reconciliation threaten to delay FISA, defe…